Greenwood Capital Associates’s Exact Sciences EXAS Stock Holding History

Greenwood Capital Associates’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,263	Closed	-$565K	–	219
2021 Q4	$565K	Sell	7,263 -841	-10%	-$74.2K	0.08%	177
2021 Q3	$773K	Buy	8,104 +72	+0.9%	+$7.6K	0.12%	136
2021 Q2	$999K	Buy	8,032 +228	+3%	+$27.2K	0.15%	113
2021 Q1	$1.03M	Sell	7,804 -235	-3%	-$32.2K	0.16%	103
2020 Q4	$1.06M	Sell	8,039 -204	-2%	-$24.7K	0.18%	99
2020 Q3	$841K	Buy	8,243 +3,922	+91%	+$339K	0.16%	88
2020 Q2	$376K	Sell	4,321 -1,354	-24%	-$108K	0.09%	123
2020 Q1	$329K	Buy	+5,675	New	+$461K	0.1%	97
2018 Q4	–	Sell	-6,581	Closed	-$519K	–	176
2018 Q3	$519K	Sell	6,581 -860	-12%	-$56.1K	0.11%	105
2018 Q2	$445K	Buy	+7,441	New	+$400K	0.1%	106

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenwood Capital Associates's EXAS Position: Q1 2022 in Review

Greenwood Capital Associates sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 7,263 shares — an estimated $565K sold.

Greenwood Capital Associates first reported a position in EXAS in Q2 2018 and held it in 10 quarters. The position peaked at $1.06M in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

Greenwood Capital Associates reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
Greenwood Capital Associates sold 7,263 Exact Sciences shares in Q1 2022, an estimated $565K.
Greenwood Capital Associates first reported a position in Exact Sciences in Q2 2018 and held it in 10 quarters.
Greenwood Capital Associates's Exact Sciences position peaked at $1.06M in Q4 2020.
559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Greenwood Capital Associates's 13F filing for Q1 2022, filed 10 May 2022.